Loading
Latest filing published 05 Aug 2026 for Camp4 Therapeutics Corp, €9,372. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Josh Mandel-Brehm appears in our data through filings on Camp4 Therapeutics Corp shares, published by SEC (Form 4). Between 15 October 2024 and 3 August 2026, the trades on record add up to 3 filings.
Every open-market trade on record is a purchase: 2 purchases worth €18k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2026: 1 purchase and no sales on the market.
The newest entry dates from 5 August 2026: an open-market purchase of €9,372, in Camp4 Therapeutics Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 2 declarations